Syneos Health

Overview

Syneos Health is a contract research organization supporting biopharmaceutical companies across the full drug development lifecycle, from preclinical through commercialization. The organization employs 26,000+ staff, including 480+ MDs and 750+ PhDs, and operates globally with deep therapeutic expertise.

Therapeutic Expertise

The company demonstrates particular strength in oncology and hematology, having helped develop or commercialize 96% of novel oncology drugs approved by the FDA and 93% of oncology products granted marketing authorization by the EMA over the last five years. Across all therapeutic areas, Syneos Health supported 89% of FDA-approved CNS drugs and 92% of general medicine drugs, as well as 83% of EMA-authorized CNS drugs and 89% of general medicine products in the same period.

Service Offerings

Clinical Development & Operations: Full-service clinical trial management and operational support across phases of development.

Regulatory Affairs: Regulatory strategy and submission support for FDA, EMA, and other major authorities.

Commercialization & Marketing: Predictive commercial solutions combining behavioral insights and market analytics to accelerate product launch and performance.

FSP Solutions: Syneos Health FSP 360 offers customized functional service provider arrangements prioritizing flexibility and fit-for-purpose delivery while maintaining sponsor visibility and control.

Differentiation

The organization emphasizes AI-driven performance enhancements that connect and harmonize data to deliver actionable insights. Project teams are assembled with specialized experts tailored to individual customer needs, extending from lab-to-life service delivery.